AU2012377476B2 - Preparation and method for the prophylaxis and treatment of atypical osteoporosis - Google Patents

Preparation and method for the prophylaxis and treatment of atypical osteoporosis Download PDF

Info

Publication number
AU2012377476B2
AU2012377476B2 AU2012377476A AU2012377476A AU2012377476B2 AU 2012377476 B2 AU2012377476 B2 AU 2012377476B2 AU 2012377476 A AU2012377476 A AU 2012377476A AU 2012377476 A AU2012377476 A AU 2012377476A AU 2012377476 B2 AU2012377476 B2 AU 2012377476B2
Authority
AU
Australia
Prior art keywords
vitamin
preparation
osteoporosis
bone
vitamins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2012377476A
Other languages
English (en)
Other versions
AU2012377476A1 (en
AU2012377476A8 (en
Inventor
Konstantin Gennad'evich ELISTRATOV
Olga JHONES
Evgenij Nikolaevich KRUTIAKOV
Villorij Ivanovich STRUKOV
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Parafarm OOO
Original Assignee
Parafarm OOO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parafarm OOO filed Critical Parafarm OOO
Publication of AU2012377476A1 publication Critical patent/AU2012377476A1/en
Publication of AU2012377476A8 publication Critical patent/AU2012377476A8/en
Application granted granted Critical
Publication of AU2012377476B2 publication Critical patent/AU2012377476B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Insects & Arthropods (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
AU2012377476A 2012-04-19 2012-08-21 Preparation and method for the prophylaxis and treatment of atypical osteoporosis Ceased AU2012377476B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
RU2012115654/15A RU2497533C1 (ru) 2012-04-19 2012-04-19 Способ и препарат для профилактики и лечения атипичного остеопороза с нормальной или повышенной минерализацией костной ткани с наличием полостных образований в трабекулярных отделах костей (и ему близких состояниях при избыточной массе и метаболическом синдроме)
RU2012115654 2012-04-19
PCT/RU2012/000687 WO2013157982A1 (ru) 2012-04-19 2012-08-21 Препарат и способ профилактики и лечения атипичного остеопороза

Publications (3)

Publication Number Publication Date
AU2012377476A1 AU2012377476A1 (en) 2014-12-11
AU2012377476A8 AU2012377476A8 (en) 2014-12-18
AU2012377476B2 true AU2012377476B2 (en) 2017-10-05

Family

ID=49383800

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2012377476A Ceased AU2012377476B2 (en) 2012-04-19 2012-08-21 Preparation and method for the prophylaxis and treatment of atypical osteoporosis

Country Status (17)

Country Link
US (1) US9827273B2 (enExample)
EP (1) EP2845598B1 (enExample)
JP (1) JP6286417B2 (enExample)
CN (1) CN104736161B (enExample)
AU (1) AU2012377476B2 (enExample)
BR (1) BR112014025990B1 (enExample)
CA (1) CA2870823C (enExample)
DK (1) DK2845598T3 (enExample)
EA (1) EA026533B1 (enExample)
ES (1) ES2616035T3 (enExample)
IL (1) IL235169B (enExample)
IN (1) IN2014DN09780A (enExample)
LT (1) LT2845598T (enExample)
PL (1) PL2845598T3 (enExample)
RU (1) RU2497533C1 (enExample)
UA (1) UA111536C2 (enExample)
WO (1) WO2013157982A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180249751A1 (en) * 2009-11-30 2018-09-06 Parapharm Llc Preparation for Treating Androgen Deficiency in Women
US20190381072A1 (en) * 2012-04-19 2019-12-19 Parapharm Llc Preparation for the Prophylaxis and Treatment of Atypical Osteoporosis
RU2498811C1 (ru) * 2012-04-19 2013-11-20 Общество С Ограниченной Ответственностью "Парафарм" Способ профилактики и лечения остеопороза и переломов костей и препарат для профилактики и лечения остеопороза и переломов костей
RU2564111C9 (ru) * 2013-07-03 2016-03-20 Общество С Ограниченной Ответственностью "Парафарм" Применение адсорбированного гомогената трутневого расплода и витаминов группы d и/или их активных метаболитов для профилактики и лечения острых респираторных заболеваний и гриппа
RU2577225C1 (ru) * 2015-03-27 2016-03-10 Общество С Ограниченной Ответственностью "Парафарм" Препарат и способ для лечения дефицита андрогенов у женщин, содержащий энтомологические протеины
EP4268688A4 (en) * 2021-04-13 2024-09-04 Samsung Electronics Co., Ltd. Cooking apparatus and control method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060252045A1 (en) * 2003-06-06 2006-11-09 Moitreyee Chatterjee-Kishore Methods and materials for identifying agents which modulate bone remodeling and agents identified thereby
WO2009101135A1 (en) * 2008-02-13 2009-08-20 Dsm Ip Assets B.V. Combined use of 25-hydroxy-vitamin d3 and vitamin d3 for improving bone mineral density and for treating osteoporosis
RU2412616C1 (ru) * 2009-11-30 2011-02-27 Общество С Ограниченной Ответственностью "Парафарм" Биологически активная добавка к пище для профилактики заболеваний остеопорозом

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1101684C (zh) * 1997-07-24 2003-02-19 薛大权 蜂蛹钙制剂

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060252045A1 (en) * 2003-06-06 2006-11-09 Moitreyee Chatterjee-Kishore Methods and materials for identifying agents which modulate bone remodeling and agents identified thereby
WO2009101135A1 (en) * 2008-02-13 2009-08-20 Dsm Ip Assets B.V. Combined use of 25-hydroxy-vitamin d3 and vitamin d3 for improving bone mineral density and for treating osteoporosis
RU2412616C1 (ru) * 2009-11-30 2011-02-27 Общество С Ограниченной Ответственностью "Парафарм" Биологически активная добавка к пище для профилактики заболеваний остеопорозом

Also Published As

Publication number Publication date
EP2845598A1 (en) 2015-03-11
IL235169B (en) 2019-10-31
ES2616035T3 (es) 2017-06-09
US20150224150A1 (en) 2015-08-13
JP6286417B2 (ja) 2018-02-28
RU2497533C1 (ru) 2013-11-10
LT2845598T (lt) 2017-02-27
CN104736161B (zh) 2021-07-06
UA111536C2 (uk) 2016-05-10
IL235169A0 (en) 2014-12-31
EP2845598B1 (en) 2017-01-04
JP2015516974A (ja) 2015-06-18
US9827273B2 (en) 2017-11-28
BR112014025990A2 (pt) 2017-06-27
PL2845598T3 (pl) 2017-07-31
AU2012377476A1 (en) 2014-12-11
BR112014025990B1 (pt) 2021-02-17
AU2012377476A8 (en) 2014-12-18
CN104736161A (zh) 2015-06-24
IN2014DN09780A (enExample) 2015-07-31
EA201401155A1 (ru) 2015-05-29
EP2845598A4 (en) 2015-10-28
CA2870823C (en) 2017-10-03
EA026533B1 (ru) 2017-04-28
WO2013157982A1 (ru) 2013-10-24
CA2870823A1 (en) 2013-10-24
DK2845598T3 (en) 2017-04-10

Similar Documents

Publication Publication Date Title
CA2870823C (en) A method for preventing and treating atypical osteoporosis with normal or increased bone tissue mineralizarion with the presence of cavities in trabecular sections of bone (and conditions similar thereto involving excess mass and metabolic syndrome)
JP2015516974A5 (ja) 骨の線維柱帯における空洞病巣発生を有する正常又は増加した骨組織石灰化に伴う非定型骨粗鬆症を対象にする予防または治療剤
AU2012377478B2 (en) Preparation and method for the prophylaxis and treatment of osteoporosis and bone fractures
AU2017203767B2 (en) Method for filling bone cavity formations with calcium
KR102491748B1 (ko) 정형외과적 질병의 치료를 위한 조성물 및 방법
BR112017007364B1 (pt) Composições farmacêuticas e usos das mesmas para o tratamento ou prevenção de deficiências de vitaminas e minerais em pacientes submetidos à cirurgia de bypass gástrico
US20190381072A1 (en) Preparation for the Prophylaxis and Treatment of Atypical Osteoporosis
Goel et al. Role of L arginine in treatment of osteoporosis
EA028560B1 (ru) Способ и препарат для лечения артритов и артрозов
NZ619215B2 (en) Method for filling bone cavities with calcium

Legal Events

Date Code Title Description
TH Corrigenda

Free format text: IN VOL 28 , NO 49 , PAGE(S) 6661 UNDER THE HEADING PCT APPLICATIONS THAT HAVE ENTERED THE NATIONAL PHASE - NAME INDEX UNDER THE NAME OBSCHESTVO S OGRANICHENNOJ OTVETSTVENNOST'JU "PARAFARM", APPLICATION NO. 2012377476, UNDER INID (71) CORRECT THE APPLICANT NAME TO OBSCHESTVO S ORGANICHENNOJ OTVETSTVENNOST'JU "PARAFARM"

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired